Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 14, 2022; 10(2): 485-491
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.485
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.485
Combined molybdenum target X-ray and magnetic resonance imaging examinations improve breast cancer diagnostic efficacy
Wen-Quan Gu, Sun-Mei Cai, Wei-Dong Liu, Qi Zhang, Ying Shi, Li-Juan Du, Department of Radiology, Punan Hospital, Shanghai 200126, China
Author contributions: Gu WQ and Du LJ designed the research study; Cai SM and Zhang Q performed the research; Yang CH contributed new reagents and analytic tools; Gu WQ and Cai SM analyzed the data and wrote the manuscript; all authors have read and approve the final manuscript.
Supported by Clinical Plateau Department, Shanghai Pudong New Area Health Construction Commission , No. PWYgy2018-04.
Institutional review board statement: The study was reviewed and approved by the Punan Hospital Institutional Review Board.
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement: No conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Li-Juan Du, MHSc, Attending Doctor, Department of Radiology, Punan Hospital, No. 279 Linyi Road, Shanghai 200126, China. haomiao2010@126.com
Received: September 9, 2021
Peer-review started: September 9, 2021
First decision: October 18, 2021
Revised: October 19, 2021
Accepted: December 3, 2021
Article in press: December 3, 2021
Published online: January 14, 2022
Peer-review started: September 9, 2021
First decision: October 18, 2021
Revised: October 19, 2021
Accepted: December 3, 2021
Article in press: December 3, 2021
Published online: January 14, 2022
Core Tip
Core Tip: Early-stage breast cancer patients often lack specific clinical manifestations, making diagnosis difficult. Molybdenum target X-ray and magnetic resonance imaging examinations both have advantages. Thus, a combined examination methodology may improve early breast cancer diagnoses. This study explored the combined diagnostic efficacy of molybdenum target X-ray examinations and magnetic resonance imaging for breast cancer. The combined methodology improved the diagnostic sensitivity and accuracy, minimizing the missed- and misdiagnoses risk and promoting timely treatment intervention.